All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Fri 2018-12-07? to Fri 2024-12-20 |
YTD
Return |
TRR
Price |
||||
---|---|---|---|---|---|---|
MRNA × |
−61.54%
2024-12-20 |
1.688 TRR
2024-12-20 |
||||
Moderna Inc NASDAQ Common Stock | ||||||
Fri 2018-12-07? to Fri 2024-12-20 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
MRNA × |
+68.84%
+9.06%/yr |
+27.99%/yr
(R2=0.240) |
||||
Moderna Inc NASDAQ Common Stock | ||||||
Fri 2018-12-07? to Fri 2024-12-20 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
MRNA × |
$10,000.00
2018-12-07 |
$16,883.84
2024-12-20 |
||||
Moderna Inc NASDAQ Common Stock | ||||||
Year | MRNA |
---|---|
2024 (YTD) | −61.54% |
2023 | −46.43% |
2022 | −33.57% |
2021 | +127.12% |
2020 | +426.94% |
2019 | +25.26% |
2018 | −17.70% |
Fri 2018-12-07? to Fri 2024-12-20 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
MRNA × | −92.97% |
−93.42%
2024-11-15 |
||||
Moderna Inc NASDAQ Common Stock | ||||||